mRNA |
crizotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0065 |
0.9 |
mRNA |
SB-743921 |
CTRPv2 |
pan-cancer |
AAC |
-0.006 |
0.9 |
mRNA |
prochlorperazine |
CTRPv2 |
pan-cancer |
AAC |
-0.0068 |
0.9 |
mRNA |
BRD-K33514849 |
CTRPv2 |
pan-cancer |
AAC |
0.025 |
0.9 |
mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0061 |
0.9 |
mRNA |
YL54 |
CTRPv2 |
pan-cancer |
AAC |
-0.0068 |
0.9 |
mRNA |
blebbistatin |
CTRPv2 |
pan-cancer |
AAC |
0.013 |
0.9 |
mRNA |
KHS101 |
CTRPv2 |
pan-cancer |
AAC |
-0.0063 |
0.9 |
mRNA |
BRD-K52037352 |
CTRPv2 |
pan-cancer |
AAC |
0.0068 |
0.9 |
mRNA |
alvocidib |
CTRPv2 |
pan-cancer |
AAC |
-0.0082 |
0.9 |